Skip NavigationSkip to Content
Return Return to Search Results

Molecular alterations in primary prostate cancer after androgen ablation therapy

  1. Author:
    Best, C. J. M.
    Gillespie, J. W.
    Yi, Y. J.
    Chandramouli, G. V. R.
    Perlmutter, M. A.
    Gathright, Y.
    Erickson, H. S.
    Georgevich, L.
    Tangrea, M. A.
    Duray, P. H.
    Gonzalez, S.
    Velasco, A.
    Linehan, W. M.
    Matusik, R. J.
    Price, D. K.
    Figg, W. D.
    Emmert-Buck, M. R.
    Chuaqui, R. F.

  2. Author Address

    NCI, Pathogenet Unit, Pathol Lab, NIH, Bethesda, MD 20892 USA. NCI, Urol Oncol Branch, NIH, Bethesda, MD 20892 USA. NCI, Mol Pharmacol Sect, Canc Therapeut Branch, NIH, Bethesda, MD 20892 USA. NCI, Sci Applicat Int Corp Frederick Inc, Frederick, MD 21701 USA. Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Div Med Genet, Dept Med, Nashville, TN USA. Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Dept Urol Surg, Nashville, TN USA. NCI, Ctr Adv Technol, Gaithersburg, MD USA. Catholic Univ Chile, Dept Pathol, Santiago, Chile. Catholic Univ Chile, Dept Urol, Santiago, Chile Best, CJM, NCI, Pathogenet Unit, Pathol Lab, NIH, Bethesda, MD 20892 USA
    1. Year: 2005
    2. Date: OCT 1
  2. Journal: Clinical Cancer Research
    1. 11
    2. 19, Part 1
    3. Pages: 6823-6834
  4. Type of Article: Article
  1. Abstract:

    Purpose: After an initial response to androgen ablation, most prostate tumors recur, ultimately progressing to highly aggressive androgen-independent cancer. The molecular mechanisms underlying progression are not well known in part due to the rarity of androgen-independent Samples from primary and-metastatic sites.Experimental Design: We compared the gene expression profiles of 10 androgen-independent primary prostate tumor biopsies with 10 primary, untreated androgen-dependent tumors. Samples were laser capture microdissected, the RNA was amplified, and gene expression was assessed using Affymetrix Human Genome U133A GeneChip. Differential expression was examined with principal component analysis, hierarchical clustering', and Student's t testing. Analysis of gene ontology was done with Expression Analysis Systematic Explorer and gene expression data were integrated with genomic alterations with Differential Gene Locus Mapping.Results: Unsupervised principal component analysis showed that the androgen-dependent and androgen-independent tumors segregated from one another. After filtering the data, 239 differentially expressed genes were identified. Two main gene ontologies were found discordant between androgen-independent and androgen-dependent tumors-macromolecule biosynthesis was clown-regulated and cell adhesion was up-regulated in androgen-independent tumors. Other differentially expressed genes were related to interleukin-6 signaling as well as angiogenesis, cell adhesion, apoptosis, oxidative stress, and hormone response. The Differential Gene Locus Mapping analysis identified nine regions of potential chromosomal deletion in the androgen-independent tumors, including 1p36, 3p2l, 6p2l, 8p2l, 11p15, 11q12,12q23,16q12, and 16q2l.Conclusions: Taken together, these data identify several unique characteristics of androgen-independent prostate cancer that may hold potential for the devellopment,of targeted therapeutic intervention

    See More

  1. Keywords:

External Sources

  1. View record in Web of Science®
  2. WOS: 000232238100013

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel